ReferencesReferences - Information and Library …shodhganga.inflibnet.ac.in/bitstream/10603/31654/15/15...References University of Delhi 121 Cai L, Chen S, Evans T, Deng DX, Mukherjee

ReferencesReferencesReferencesReferences

References

University of Delhi 118

8. REFERENCES

Ahlborg G, Shemyakin A, Böhm F, Gonon AT, Pernow J. Dual endothelin receptor

blockade acutely improves insulin sensitivity in obese patients with insulin resistance

and coronary artery disease. Diabetes Care 2007; 30(3): 591–6.

Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi SM, Farhangi A, Verdi AA,

Mofidian SM, Rad BL. Induction of diabetes by Streptozotocin in rats. Indian J Clin

Biochem 2007; 22 (2): 60-64.

Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH. Effect of the Magnitude of Lipid

Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer: Insights

From Large Randomized Statin Trials. J Am Coll Cardiol 2007; 50 (5): 409–418.

Amour J and Kersten JR. Diabetic Cardiomyopathy and Anesthesia: Bench to Bedside.

Anesthesiology 2008; 108: 524–530.

Andallu B, Vinay Kumar AV, Varadacharyulu NC. Lipid abnormalities in

streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves. Int J Diab

Dev Ctries 2009; 29: 123-8.

Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, Nath LM, Das

AK, Madhu SV, Rao PV, Shukla DK, Kaur T, Ali MK, Mohan V. The Indian Council

of Medical Research–India Diabetes (ICMR–INDIAB) Study: Methodological Details.

J Diabetes Sci Techno 2011; 5(4): 906–914.

Anjaneyulu ASR, Prasad AVR. Structure of terminic acid, a dihydroxy triterpene

carboxylic acid from Terminalia arjuna. Phytochemistry 1983; 22: 993–998.

Annonu AK, Fattah AA, Mokhtar MS, Ghareeb S, Elhendy A. LV systolic and

diastolic functional abnormalities in asymptomatic patients with non-insulin-

dependent diabetes mellitus. J Am Soc Echocardiogr 2001; 14: 885–891.

Apfel SC. Neurotrophic factors and diabetic peripheral neuropathy. Eur Neurol 1999;

41(Suppl. 1): 27–34.

References


Armati PJ and Pollard JD. Immunology of the Schwann cell. Baillieres Clin Neurol

1996; 5: 47–64.

Arnold JM, Yusuf S, Young J, Mathew J, Johnstone D, Avezum A, Lonn E, Pogue J,

Bosch J. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention

Evaluation (HOPE) Study. Circulation 2003; 107:1284-1290.

Baillard C, Mansier P, Ennezat PV, Mangin L, Medigue C, Swynghedauw B,

Chevalier B. Converting enzyme inhibition normalizes QT interval in spontaneously

hypertensive rats. Hypertension 2000; 36: 350–354.

Balakumar P and Singh M. The possible role of caspase-3 in pathological and

physiological cardiac hypertrophy in rats. Basic Clin Pharmacol Toxicol 2006; 99:

418–424.

Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden

unexpected death in chronic heart failure. Lancet 1994; 343: 327-329.

Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920; 7:

353–370.

Benveniste EN. Cytokine actions in the central nervous system. Cytokine Growth

Factor Rev 1998; 9: 259–275.

Berne RM and Levy MN. The Heart Generates its own pacemaker activity. In

Cardiovascular Physiology, 8th ed., Mosby, Inc, St Louis, MA, 2001: 28-38.

Bertoni A G, Tsai A, Kasper EK, Brancati FL. Diabetes and idiopathic

cardiomyopathy. Diabetes Care 2003; 26: 2791–2795.

Bestetti RB and Oliveira JSM. The surface electrocardiogram: a simple and reliable

method for detecting overt and latent heart disease in rats. Braz J Med Biol Res 1990;

23: 1213–1222.

Bharani A, Ganguli LK, Mathur YJ, Raman PG. Efficacy of Terminalia arjuna in

chronic stable angina: a double-blind, placebo-controlled, crossover study comparing

Terminalia arjuna with isosorbide mononitrate. Indian Heart J 2002; 54: 170–175.

References


Bhatia J. Study of the possible cardioprotective role of Terminalia arjuna in

experimental animals and its clinical usefulness in coronary artery disease. MD

(Pharmacology) thesis, University of Delhi, India 1998.

Bhatia J, Bhattacharya SK, Mahajan P, Dwivedi S. Effect of Terminalia arjuna on

coronary flow - an experimental study (Abstract). Indian J Pharmacol 1998; 30: 118.

Bhatia J, Bhattacharya SK, Mahajan P, Dwivedi S. Experimental evaluation of

cardiovascular and cardioprotective effects of Terminalia arjuna. Indian J Pharmacol

1999; 31: 57.

Bhatia J, Bhattacharya SK, Mahajan P, Dwivedi S. Effect of Terminalia arjuna on blood

pressure of anaesthetized dogs (Abstract). Indian J Pharmacol 2000; 32: 159–160.

Böhm F and Pernow J. The importance of endothelin-1 for vascular dysfunction in

cardiovascular disease. Cardiovasc Res 2007; 76: 8–18.

Borges GR, Oliveira MD, Salgado HC, Fazan R. Myocardial performance in

conscious Streptozotocin diabetic rats. Cardiovasc Diabetol 2006; 5: 26.

Boudina S and Dale Abel E. Diabetic Cardiomyopathy Revisited. Circulation 2007;

115: 3213-3223.

Brownlee M. Biochemistry and molecular cell biology of diabetic complications.

Nature 2001; 414: 813–20.

Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC,

Litwin SE, Abel ED. Reduced cardiac efficiency and altered substrate metabolism

precedes the onset of hyperglycemia and contractile dysfunction in two mouse models

of insulin resistance and obesity. Endocrinology 2005; 146: 5341–5349.

Burena TV, Kasbergena CM, Gispena WH, Wildta DJD. In vivo cardiovascular

reactivity and baroreflex activity in diabetic rats. Cardiovasc Res 1998; 38: 763-771.

Cai L and James Kang Y. Oxidative stress and diabetic cardiomyopathy. A brief

review. Cardiovasc Toxicol 2001; 1: 181-193.

References


Cai L, Chen S, Evans T, Deng DX, Mukherjee K, Chakrabarti S. Apoptotic germ-cell

death and testicular damage in experimental diabetes: prevention by endothelin

antagonism. Urol Res 2000; 28: 342–7.

Caius JS, Mhaskar KS, Isaacs M. A comparative study of the dried barks of the

commoner Indian species of genus Terminalia. Indian Medical Research Memoirs

1930; 16: 51–75.

Calcutt NA, Allendoerfer KL, Mizisin AP, Middlemas A, Freshwater JD, Burgers M

Ranciato R, Delcroix JD, Taylor FR, Shapiro R, Strauch K, Dudek H, Engber TM,

Galdes A, Rubin LL, Tomlinson DR. Therapeutic efficacy of sonic hedgehog protein

in experimental diabetic neuropathy. J Clin Invest 2003; 111: 507–514.

Cameron NE, and Cotter M A. Metabolic and vascular factors in the pathogenesis of

diabetic neuropathy. Diabetes 1997; 46 (Suppl.): S31–S37.

Cardoso CR, Salles GF, Deccache W. QTc interval prolongation is a predictor of

future strokes in patients with type 2 diabetes mellitus. Stroke 2003; 34(9): 2187-2194.

Carll AP, Haykal-Coates N, Winsett DW, Rowan WH, Hazari MS, Ledbetter AD,

Nyska A, Cascio WE, Watkinson WP, Costa DL, Farraj AK. Particulate matter

exposure exacerbates cardiopulmonary injury in a rat model of Isoproterenol-induced

cardiomyopathy. Inhal Toxicol 2010; 22(5): 355–368.

Carlson LA. Can higher level of HDL cholesterol augments cardiovascular disease

prevention? The combination statins-nicotinic acid increases the level of HDL and

reduces the level of LDL cholesterol. Lakartidningen 2006; 103: 3283-3285.

Carlson CD, Bai Y, Jonakait GM, Hart RP. Interleukin-1 beta increases leukemia

inhibitory factor mRNA levels through transient stimulation of transcription rate. Glia

1996: 18: 141– 151.

Carrier GO and Aronstam RS. Altered muscarinic receptor properties and function in

the heart in diabetes. J Pharmacol Exp Ther 1987; 242: 531-535.

References


Carrier GO, Edwards AD, Aronstam RS. Cholinergic supersensitivity and decreased

number of muscarinic receptors in atria from short term diabetic rats. J Mol Cell

Cardiol 1984; 16: 963-965.

Castelli WP, Garrison RJ, Wilson PWF. Incident of coronary heart disease and

lipoprotein cholesterol levels: The Framingham study. J Am Med Assn 1986; 256:

2835-2838.

Chander R, Singh K, Khanna AK, Kaul SM, Puri A, Saxena R, Bhatia G, Rizvi F,

Rastogi AK. Antidyslipidemic and antioxidant activities of different fractions of

Terminalia arjuna stem bark. Indian J Clin Biochem 2004; 19: 141-148.

Chang KSK and Lund DD. Alterations in the baroreceptor reflex control of heart rate

in Streptozotocin diabetic rats. J Mol Cell Cardiol 1986; 18: 617-624.

Chatham JC, Forder JR, McNeill JH. The heart in diabetes. Norwell: MA Kluwer

Academic Publishers, 1996.

Chen Y, Saari JT, Kang YJ. Weak antioxidant defenses make the heart a target for

damage in copper-deficient rats. Free Radical Biol Med 1994; 17: 529–36.

Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S. Diabetes-induced

myocardial structural changes: role of endothelin-1 and its receptors. J Mol Cell

Cardiol 2000; 32: 1621–1629.

Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer

WJ, Matlib MA. Defective intracellular Ca (2+) signaling contributes to

cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2002; 283:

H1398-H1408.

Chopra RN, Chopra IC, Handa KL, Kapur LD. Terminalia arjuna W&A

(Combretaceae). In: Chopra RN, Chopra IC, Handa KL, Kapur LD (Eds.), Chopra’s

Indigenous Drugs of India, 1st ed. UN Dhur & Sons, Calcutta, India, 1958: 421–424.

Chopra RN and Ghosh S. Terminalia arjuna: its chemistry, pharmacology and

therapeutic action. Ind Med Gaz 1929; 64: 70–73.

References


Choubey BK and Srivastava SK. Antifungal agents from Terminalia arjuna. Indian J

Chem 2001; 40B: 354–356.

Christensen PK, Gall MA, Major-Pedersen A, Sato A, Rossing P, Breum L, Pietersen

A, Kastrup J, Parving HH. QTc interval length and QT dispersion as predictors of

mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest

2000; 60 (4): 323-332.

Cilla DD Jr, Gibson DM, Whitfield LR, Sedman AJ. Pharmacodynamic effects and

pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects

in the morning and evening. J Clin Pharmacol 1996; 36(7): 604-609.

Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman

WB, Loeb H, Wong M, et al. A comparison of enalapril with hydralazine-isosorbide

dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:

303–310.

Creange A, Barlovatz-Meimon G, Gherardi RK. Cytokines and peripheral nerve

disorders. Eur Cytokine Netw 1997; 8: 145– 151.

Dale KM, Coleman CI, Henyan NN, Kluger J, White CM. Statins and cancer risk: a

meta-analysis. JAMA 2006; 295 (1): 74–80.

Dall'Ago P, Fernandes TG, Machado UF, Belló AA, Irigoyen MC. Baroreflex and

chemoreflex dysfunction in Streptozotocin-diabetic rats. Braz J Med Biol Res 1997;

30: 119-124.

Das J, Vasan V, Sil PC. Taurine exerts hypoglycemic effect in alloxan-induced

diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart

and ameliorates cardiac oxidative stress and apoptosis. Toxicol Appl Pharmacol 2012;

258: 296–308.

Davì G, Chiarelli F, Santilli F, Pomilio M, Vigneri S, Falco A, Basili S, Ciabattoni G,

Patrono C. Enhanced lipid peroxidation and platelet activation in the early phase of

type1 diabetes mellitus role of interleukin-6 and disease duration. Circulation 2003;

107: 3199-3203.

References


De Angelis K, Schaan BD, Maeda CY, Dall’Ago P, Wichi RB, Irigoyen MC.

Cardiovascular control in experimental diabetes. Braz J Med Biol Res 2002; 35: 1091-

1100.

De Angelis KLD, Dall'Ago P, Gadonski G, Peixoto LRA, Fernandes TG, Irigoyen

MC. Exercise training improves cardiovascular and metabolic status in diabetic rats.

Hypertension 1999; 33: 1073 (Abstract).

Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines

and cytokine receptors in advanced heart failure: an analysis of the cytokine database

from the Vesnarinone trial (VEST). Circulation 2001; 103: 2055-2059.

Dickinson MG, John H, Olshansky B Hellkamp AS, Anderson J, Poole JE, Mark DB,

Lee KL, Bardy GH. Statin use was associated with reduced mortality in both ischemic

and nonischemic cardiomyopathy and in patients with implantable defibrillators. Am

Heart J 2007; 153: 573-578.

Dincer UD, Bidasee KR, Guner S, Tay A, Ozcelikay AT, Altan VM. The effect of

diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts.

Diabetes 2001; 50: 455–61.

Dinh W, Füth R, Nickl W, Krahn T, Ellinghaus P, Scheffold T, Bansemir L, Bufe A,

Barroso MC, Lankisch M. Elevated plasma levels of TNF-alpha and Interleukin-6 in

patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc

Diabetol 2009; 8: 58.

Donatelli M, Colletti I, Bucalo ML, Russo V, Verga S. Plasma endothelin levels in

NIDDM patients with macroangiopathy. Diabetes Res 1994; 25: 159-164.

Dwivedi S, Jauhari R, Varshney A. Terminalia arjuna the cardiovascular friendly

plant. Atherosclerosis 1997; 134: 47.

Dwivedi S. Terminalia arjuna Wight & Arn - a useful drug for cardiovascular

disorders. J Ethnopharmacol 2007; 114(2): 114-29.

Dwivedi S. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous

drug, in coronary heart disease. J Assoc Physicians India 1994; 42: 287–289.

References


Dwivedi S, Chansouria JPN, Somani PN, Udupa KN. Influence of certain indigenous

drugs on the PGE like activity in the ischemic rabbit aorta. Indian Drugs 1987; 2:

378–382.

Dwivedi S, Somani PN, Chansouria JPN, Udupa KN. Cardioprotective effects of

certain indigenous drugs in myocardial ischemia in rabbits. Indian J Exp Biol 1988;

26: 969–975.

Dwivedi S, Udupa N. Terminalia arjuna: pharmacognosy, phytochemistry,

pharmacology and clinical use. A review. Fitoterapia 1989; 60: 413–420.

Eckberg DL, Harkins SW, Fritsch JM, Musgrave GE, Gardner DF. Baroreflex control

of plasma norepinephrine and heart period in healthy subjects and diabetic patients. J

Clin Invest 1986; 78: 366-374.

Eichberg J. Protein kinaseCchanges in diabetes: Is the concept relevant to neuropathy?

Int Rev Neurobiol 2002; 50: 61–82.

Elangovan V, Shohami E, Gati I, Kohen R. Increased hepatic lipid soluble antioxidant

capacity as compared to other organs of streptozotocin-induced diabetic rats: a cyclic

voltametry study. Free Radical Res 2000; 32: 125–34.

Elias D, Prigozin H, Polak N, Rapoport M, Lohse A W, Cohen I R. Autoimmune

diabetes induced by the b - Cell toxin STZ. Diabetes 1994; 43: 992-998.

Erbas T, Erbas B, Kabakci G, Aksoyek S, Koray Z, Gedik O. Plasma big-endothelin

levels, cardiac autonomic neuropathy, and cardiac functions in patients with

insulindependent diabetes mellitus. Clin Cardiol 2000; 23: 259–263.

Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L,

Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased

by hyperglycemia in humans. Role of oxidative stress. Circulation 2002; 106:

2067-2072.

Farraj AK, Hazari MS, Cascio WE. The Utility of the Small Rodent Electrocardiogram

in Toxicology. Toxicological Sciences 2011; 121(1): 11–30.

References


Fein FS, Kornstein LB, Strobeck JE, Capasso JM, Sonnenblick EH. Altered

myocardial mechanics in diabetic rats. Circ Res 1980; 47: 922-933.

Fein FS, Strobeck JE, Malhotra A, Scheuer J, Sonnenblick EH. Reversibility of

diabetic cardiomyopathy with insulin in rats. Circ Res 1981; 49:1251-1261.

Fein FS. Diabetic cardiomyopathy. Diabetes Care 1990; 13: 1169 –1179.

Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old

problem. J Clin Invest 2003; 111: 431–433.

Ferretti G, Rabini RA, Bacchetti T, Vignini A, Salvolini E, Ravaglia F, Curatola G,

Mazzanti L. Glycated low density lipoproteins modify platelet properties: A

compositional and functional study. Clin Endocrinol Metab 2002; 87: 2180-4.

Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative

inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:

387-389.

Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J. Myocyte

death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab Invest

2000; 80: 531–7.

Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B,

Anversa P. Myocardial cell death in human diabetes. Circ Res 2000; 87: 1123–32.

Fukuchi M and Giaid A. Expression of endothelin-1 and endothelin-converting

enzyme-1 mRNAs and proteins in failing human hearts. J Cardiovasc Pharmacol

1998; 31 (Suppl. 1): S421–S423.

Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and

morbidity: the WHO mutinational study of vascular disease in diabetes. Diabetologia

2001; 44 Suppl 2: S54-64.

Furberg CD. Natural Statins and Stroke Risk. Circulation 1999; 99: 185–188.

References


Futh R, Dinh W, Bansemir L, Ziegler G, Bufe A, Wolfertz J, Scheffold T, Lankisch

M. Newly detected glucose disturbance is associated with a high prevalence of

diastolic dysfunction: double risk for the development of heart failure? Acta Diabetol

2009; 46: 335-338.

Gaist D, Jeppesen U, Andersen M, García Rodríguez LA, Hallas J, Sindrup SH.

Statins and risk of polyneuropathy - a case-control study. Neurology 2002; 58: 1333–

1337.

Gandhi MJ, Suvarna TT. Cardiovascular Complications in Diabetic Ketoacidosis. Int j

diab dev Countries 1995; 15:132-133.

Garcia MJ, Mc Namara PM, Gordon T, Kannel WB. Morbidity and mortality in

diabetics in the Framingham population: sixteen year follow-up study. Diabetes 1974;

23:105–111.

Ghosh S. Annual report of the Calcutta School of Tropical Medicine. Institute of

Hygiene and the Carmichel Hospital for Tropical Diseases, Calcutta, India.1926.

Ghoshal LM. Terminalia arjuna. Ph.D. thesis, Calcutta University, Calcutta, India.

1909.

Given MB, Jie O, Zhao X, Giles TD, Greenberg SS. Protein kinase C isozymes in

skeletal muscles during the early stage of genetic and streptozotocin diabetes. Proc

Soc Exp Biol Med 1998; 218: 382–9.

Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence

for a mitochondrial mechanism. Am J Cardiovasc Drugs 2008; 8 (6): 373–418.

Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ. Herpes simplex-

mediated gene transfer of nerve growth factor protects against peripheral neuropathy

in streptozotocin induced diabetes in the mouse. Diabetes 2002; 51: 2227–2232.

Gotto AM. Statins, cardiovascular disease, and drug safety. Am J Cardiol 2006;

97(8A): 3C-5C.

Greene DA, Stevens MJ, Obrosova I, Feldman EL. Glucose-induced oxidative stress and

programmed cell death in diabetic neuropathy. Eur J Pharmacol 1999; 375: 217–223.

References


Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoeb lP, et al .

Enhanced serum levels of thiobarbituric acid reactive substances in diabetes mellitus.

Am J Med 1995; 98: 469-75.

Gupta LP. Studies on cardiac muscle regeneration under the influence of certain

indigenous drugs. Ph.D. thesis, Banaras Hindu University, Varanasi, India.1974.

Gupta LP, Sen SP, Udupa KN. Pharmacological studies on Terminalia arjuna. Journal

of Research in Indian Medicine, Yoga and Homeopathy 1976; 11: 16–24.

Gupta R, Singhal S, Goyle A, Sharma VN. Antioxidant and hypocholesterolemic

effects of Terminalia arjuna tree-bark powder: A randomized placebo-controlled trial.

J Assoc Physicians India 2001; 49: 231–235.

Guvener N, Aytemir K, Aksoyek S, Gedik O. Plasma endothelin-1 levels in non-

insulin dependent diabetes mellitus patients with macrovascular disease. Coron Artery

Dis 1997; 8: 253-258.

Haas SJ, Hageali R, Priestly BG, Tonkin A, Demos L, McNeil JJ, Nelson M. Long

term safety of statins should be monitored. BMJ 2006; 333: 656.

Hammes HP. Aminoguanidine treatment inhibits the development of experimental

diabetic retinopathy. Proc Natl Acad Sci USA 1991; 88: 11555–9.

Hanai J, Cao P, Tanksale P, Imamura S, Koshimizu E, Zhao J, Kishi S, Yamashita M,

Phillips PS, Sukhatme VP, Lecker SH. The muscle-specific ubiquitin ligase atrogin-

1/MAFbx mediates statin-induced muscle toxicity. J Clin Invest 2007; 117 (12): 3940–

3951.

Hayashidani S, Tsutsui H, Shiomi T, Suematsu N, Kinugawa S, Ide T, Wen J,

Takeshita A. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase

inhibitor, attenuates left ventricular remodeling and failure after experimental

myocardial infarction. Circulation 2002; 105: 868–873.

Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms,

diagnosis and treatment. Clinical Science 2004; 107: 539–557.

References


Haynes WG and Webb DJ. Endothelin as a regulator of cardiovascular function in

health and disease. J Hypertens 1998; 16: 1081-1098.

Henneberger A, Zareba W, Ibald-Mulli A, Ruckerl R, Cyrys J, Couderc JP, Mykins B,

Woelke G, Wichmann HE, Peters A. Repolarization changes induced by air pollution

in ischemic heart disease patients. Environ Health Perspect 2005; 113: 440–446.

Herlitz J, Malmberg K, Karlsson B, Ryden L, Hjalmarson A. Mortality and morbidity

during a five year follow up of diabetics with myocardial infarction. Acta Med Scand

1988; 24: 31–38.

Hileeto D, Cukiernik M, Evans T, Chen S, Mukherjee S, Downey D, Karmazyn M,

Chakrabarti S. Interaction of endothelin-1 and sodium/hydrogen exchanger-1 in the

pathogenesis of diabetes induced changes in the heart. Diabetes 2001; 50 (Suppl. 2):

A155 (Abstract).

Hirsch J, Leibel RL, Mackintosh R, Aguirre A. Heart rate variability as a measure of

autonomic function during weight change in humans. Am J Physiol 1991; 261: R1418-

R1423.

Homma S, Yamazaki Y and Karakida T. Blood pressure and heart rate relationships

during cervical sympathetic and vagus nerve stimulation in streptozotocin diabetic

rats. Brain Research 1993; 629: 342-344.

Honda T, Murae T, Tsuyuki T, Takahashi T. The structure of arjungen: a new

sapogenin from Terminalia arjuna. Chemical & Pharmaceutical Bulletin 1976; 24:

178–180.

Hopfner RL, Gopalakrishnan V. Endothelin: emerging role in diabetic vascular

complications. Diabetologia 1999; 42: 1383-1394.

Hopfner RL, McNeill JR, Gopalakrishnan V. Endothelin plasma levels and endothelin-

1 evoked vascular responses at different temporal stages of diabetes in streptozotocin

diabetic rats. Eur J Pharmacol 1999; 374: 221-227.

References


Horwich T B, MacLellan WR, Fonarow GC. Statin therapy is associated with

improved survival in ischemic and nonischemic heart failure. J Am Coll Cardiol 2004;

43: 642–648.

Hounsom L, Corder R, Patel J, Tomlinson DR. Oxidative stress participates in the

breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia.

2001; 44: 424–428.

Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28: 613-

23.

Hu JR, von Harsdorf R, Lang RE. Endothelin has potent inotropic effects in rat atria.

Eur J Pharmacol 1988; 158: 275–278.

Idris I, Gray S, Donnelly R. Protein kinase C activation: isozymespecific effects on

metabolism and cardiovascular complications in diabetes. Diabetologia 2001; 44:

659–673.

Ing DJ, Zang J, Dzau VJ, Webster KA, Bishopric NH. Modulation of cytokine-

induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res 1999; 84:

21-33.

Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS,

Ballas LM, Heath WF, Stramm LE, Feener EP, King GL. Amelioration of vascular

dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996; 272: 728–

731.

Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Positive chronotropic

effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers

Arch 1988; 413: 108–110.

Jackson CV and Carrier GO. Influence of short-term experimental diabetes on blood

pressure and heart rate in response to norepinephrine and angiotensin II in the

conscious rat. J Cardiovasc Pharmacol 1983; 5: 260-265.

References


Jaganathan S, Kandaswamy K, Marcus LMD, Guruprasad K, Thakur US, Mishra SK.

Atorvastatin restores the impaired vascular endothelium-dependent relaxations

mediated by Nitric oxide and endothelium-derived hyperpolarizing factors but not

hypotension in sepsis. J Cardiovasc Pharmacol 2009; 54: 526-534.

Januszewski AS, Alderson NL, Metz TO, Thorpe SR, Baynes JW. Role of lipids in

chemical modification of proteins and development of complications in diabetes.

Biochem Soc Trans 2003; 31: 1413–1416.

Jeong IK, King GL. New Perspectives on Diabetic Vascular Complications: The Loss

of Endogenous Protective Factors Induced by Hyperglycemia. Diabetes Metab J 2011;

35: 8-11.

Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F,

Nadal-Ginard B, Leri A, Anversa P. IGF-1 overexpression inhibits the development of

diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001;

50: 1414–1424.

Kakkar R, Kalra J, Mantha SV, Prasad K. Lipid peroxidation and activity of

antioxidant enzymes in diabetic rats. Mol Cell Biochem 1995; 151: 113–9.

Kang YJ. Molecular and cellular mechanisms of cardiotoxicity. Environ Health

Perspect 2001; 109: 27–34.

Kannel WB. Lipids, diabetes, and coronary heart disease: Insights from the

Framingham Study. Am Heart J 1985; 110: 1100-1107.

Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure:

The Framingham Study. Am J Cardiol 1976; 34: 29–34.

Karamsetty M, Ferrie TJ, Kane KA, Gray AI. Effects of an aqueous extract of Terminalia

arjuna on isolated rat atria and thoracic aorta. Phytother Res 1995; 9: 575–578.

Karmazyn M, Gan XT, Humphreys RA, Yoshida H, Kusumoto K. The myocardial

Na(C)-H(C) exchange: Structure, regulation and its role in heart disease. Circ Res

1999; 85: 777–786.

References


Katayama S and Lee JB. Hypertension in experimental diabetes mellitus, renin–

prostaglandin interaction. Hypertension 1985; 7: 554–561.

Kedlaya R and Udupa SL. Glyco-oxidation of proteins: an in vitro study (Abstract). In:

Proceedings of the 10th Annual Conference of Indian Society for Atherosclerosis

Research and International Symposium on Cardiovascular Disease, Central Drug

Research Institute, Lucknow, India, 7–9 November ,1997.

Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z,

Campochiaro PA, Semenza GL. Cell type-specific regulation of angiogenic growth factor

gene expression and induction of angiogenesis in nonischemic tissue by a constitutively

active form of hypoxia-inducible factor 1. Circ. Res 2003; 93: 1074–1081.

King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence,

numerical estimates, and projections. Diabetes Care 1998; 21:1414 –1431.

Kishi T, Hirooka Y, Konno S, Sunagawa K. Atorvastatin improves the impaired

baroreflex sensitivity via anti-oxidant effect in the rostral ventrolateral medulla of

SHRSP. Clin Exp Hypertens 2009; 31: 698-704.

Klein BEK, Klein R, McBride PE, Moss SE, Prineas RJ, Reinke JO.

Electrocardiographic abnormalities in individuals with long-duration type 1diabetes.

Diabetes care 2005; 28: 145-147.

Krizsan-Agbas D and Buñag RD. Normotensive diabetic BB/W rats show enhanced

reflex tachycardia. Diabetes 1991; 40: 1504-1510.

Kucharska J, Braunova Z, Ulicna O, Zlatos L, Gvozdjakova A. Deficit of coenzyme Q

in heart and liver mitochondria of rats with streptozotocin-induced diabetes. Physiol

Res 2000; 49: 411–8.

Kumar S, Enjamoori R, Jaiswal A, Ray R, Seth S, Maulik SK. Catecholamine-induced

myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb). J

Pharm Pharmacol 2009; 61: 1529–1536.

References


Kusaka M, Kishi K, Sokabe H. Does so-called Streptozocin hypertension exist in rats?

Hypertension 1987; 10: 517–521.

La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex

sensitivity and heart-rate variability in prediction of total cardiac mortality after

myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial

Infarction) Investigators. Lancet 1998; 351(9101): 478-484.

La Rovere MT, Pinna GD, Raczak, G. Baroreflex Sensitivity: Measurement and

Clinical Implications. Ann Noninvasive Electrocardiol 2008; 13(2): 191-207.

Lechleitner M, Koch T , Herold M , Dzien A, Hoppichler F. Tumour necrosis factor-

alpha plasma level in patients with type 1 diabetes mellitus and its association with

glycaemic control and cardiovascular risk factors. J Intern Med 2000; 248: 67 – 76.

Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications

of echocardiographically determined left ventricular mass in the Framingham Heart

Study. N Engl J Med 1990; 322: 1561–1566.

Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN. Overexpression of

metallothionein reduces diabetic cardiomyopathy. Diabetes 2002; 51: 174–181.

Lieu AT and Reid JJ. Changes in the responsiveness to endothelin-1 in isolated atria

from diabetic rats. Eur J Pharmacol 1994; 261: 33–42.

Lin TC, Chien SC, Chen HF, Hsu FL. Tannins and related compounds from

Combretaceae plants. Chinese Pharmaceutical Journal 2001; 52: 1–26.

Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S. Abnormal cardiac

function in Streptozotocin diabetic rat. The j clin investigation 1990; 86: 481-488.

Lyons TJ. Lipoprotein glycation and its metabolic consequences. Diabetes 1992; 41:

67-73.

Maeda CY, Fernandes TG, Lulhier F, Irigoyen MC. Streptozotocin modifies arterial

pressure and baroreflex sensitivity in rats. Braz J Med Biol Res 1995; 28: 497-501.

References


Maeda CY, Fernandes TG, Timm HB, Irigoyen MC. Autonomic dysfunction in short-

term experimental diabetes. Hypertension 1995; 26: 1000-1004.

Makino A and Kamata K. Elevated plasma endothelin-1 level in Streptozotocin-

induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1.

Br J Pharmacol 1998; 123: 1065-1072.

Mallikarjuna K, Thomas JF, Kane KA. Phytother Res 1995; 9: 575-578.

Malstrom B, Andreesson L, Reinhammer B. In The Enzymes. Boyer P editor, XIIB

Academic press, New York 1975:533.

Manna P, Ghosh J, Das J, Sil PC. Streptozotocin induced activation of oxidative stress

responsive splenic cell signalling pathways: protective role of arjunolic acid. Toxicol

Appl Pharmacol 2010; 244: 114-29.

Manna P, Sinha M, Sil PC. Aqueous extract of Terminalia arjuna prevents carbon

tetrachloride induced hepatic and renal disorders. BMC Complement Altern Med 2006;

6: 33–44.

Maser RE and Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes

mellitus: Clinical manifestations, consequences, and treatment. J Clin Endocrinol

Metabol 2005; 90: 5896–5903.

Maulik K and Katiyar SK. Terminalia arjuna in Cardiovascular Diseases: Making the

Transition from Traditional to Modern Medicine in India. Curr Pharm Biotechnol

2010; 11: 855-860.

McDowell TS, Chapleau MW, Hajduczok G, Abboud FM. Baroreflex dysfunction in

diabetes mellitus. I. Selective impairment of parasympathetic control of the heart rate.

Am J Physiol 1994; 266: H235-H243.

Miettinen TA. Diurnal variation of cholesterol precursors squalene and methyl sterols

in human plasma lipoproteins. J Lipid Res 1982; 23 (3): 466–73.

Mizisin AP, Calcutt NA, Tomlinson DR, Gallagher A, Fernyhough P. Neurotrophin- 3

reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. J Peripher

Nerv Syst 1999; 4: 211–221.

References


Monteagudo PT, Moises VA, Kohlmann Jr O, Ribeiro AB, Lima VC, Zanella MT.

Influence of autonomic neuropathy upon LV dysfunction in insulin-dependent diabetic

patients. Clin Cardiol 2000; 23: 371–375.

Mukherjee S, Evans T, Chen S, Cukiernik M, Hileeto D, Karmazyn M, Chakrabarti, S.

Nitric oxide in diabetic hearts. Can J Diabetes Care 2001; 25: 192.

Muller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani

G, Illig T, Thorand B, Kolb H. Impaired glucose tolerance is associated with increased

serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not

TNF-alpha or its receptors. Diabetologia 2002; 45: 805-812.

Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular Actions of Insulin.

Endocr Rev 2007; 28: 463–491.

Mustonen J, Mantysaari M, Kuikka J. Vanninen E, Vainio P, Länsimies E, Uusitupa

M. Decreased myocardial 123I-metaiodobenzylguanidine uptake is associated with

disturbed LV diastolic filling in diabetes. Am Heart J 1992; 123: 804–805.

Nadkarni AK, Nadkarni KM. Indian Materia Medica, 1st ed. Popular Book Depot,

Bombay India 1954: 1198.

Nadler J and Winer L. Free radicals, nitric oxide and diabetic complications. In:

Diabetes Mellitus, edited by LeRoith D, Taylor SI and Olefsky M. Philadelphia,

Lippincott-Raven.1996: 840-848.

Nagamoto-Combs K, Vaccariello SA, Zigmond RE. The levels of leukemia inhibitory

factor mRNA in a Schwann cell lines are regulated by multiple second messenger

pathways. J Neurochem 1999; 72: 1871–1881.

Nakamura S. Progression of nephropathy in spontaneous diabetic rats is prevented by

OPB-9195, a novel inhibitor of advanced glycation. Diabetes 1997; 46: 895–899.

Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y et al.

Normalizing mitochondrial superoxide production blocks three pathways of

hyperglycaemic damage. Nature 2000; 404: 787–790.

References


Nissen S, Nicholls S, Sipahi I, Libby P, Raichlen J, Ballantyne C, Davignon J, Erbel

R, Fruchart J, Tardif J, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M,

Tuzcu E. Effect of very high-intensity statin therapy on regression of coronary

atherosclerosis: the ASTEROID trial. JAMA 2006; 295 (13): 1556–1565.

Node K, Fujita M, Kitakaze M, Hori M, Liao JK. Short-term statin therapy improves

cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.

Circulation 2003; 108: 839–843.

Norby FL, Wold LE, Duan J, Hintz KK, Ren J. IGF-I attenuates diabetes-induced

cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol

Metab 2002; 283: E658–666.

Obrosova IG, Fathallah L, Stevens MJ. Taurine counteracts oxidative stress and nerve

growth factor deficit in early experimental diabetic neuropathy. Exp Neurol 2001; 172:

211–219.

Ohuwa T, Sato Y, Naoi M. Hydroxyl radical formation in diabetic rats induced by

streptozotocin. Life Sci 1995; 56: 1789–1798.

Ommen SR and Nishimura RA. A clinical approach to the assessment of left

ventricular diastolic function by Doppler echocardiography: update. Heart 2003; 89:

18–23.

Osculati G, Grassi G, Giannattasio C, Seravalle G, Valagussa,F. Zanchetti A, Mancia

G. Early alterations of the baroreceptor control of heart rate in patients with acute

myocardial infarction. Circulation 1990; 81: 939–948.

Palmieri V, Bella JN, Tracy RP, Roman MJ, Liu JE, Best LG, Bella JN, Robbins DC,

Howard BV, Devereux RB. Relationship of left ventricular hypertrophy to

inflammation and albuminuria in adults with type 2 diabetes. The Strong Heart Study.

Diabetes Care 2003; 26: 2764–2769.

Pan Z, Sampath D, Jackson G, Werrbach-Perez K, Perez-Polo R. Nerve growth factor

and oxidative stress in the nervous system. Adv Exp Med Biol 1997; 429: 173–193.

References


Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM. Multiple pathways of

neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative

stress. J Neurosci 1998; 18: 830–840.

Parmantier E, Lynn B, Lawson D, Turmaine M, Namini SS, Chakrabarti L, McMahon

AP, Jessen KR, Mirsky R. Schwann cell-derived Desert hedgehog controls the

development of peripheral nerve sheaths. Neuron 1999; 23: 713–724.

Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M. Mechanistic clues in the

cardioprotective effect of Terminalia arjuna bark extract in Isoproterenol-induced

chronic heart failure in rats. Cardiovasc Toxicol 2011; 11: 48–57.

Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M. Terminalia arjuna enhances

baroreflex sensitivity and myocardial function in Isoproterenol-induced chronic heart

failure rats. J Cardiovasc Pharmacol Ther 2012; 17: 199-207.

Patterson D, Dick JBC, Struthers AD. Intensive statin treatment improves baroreflex

sensitivity: another cardioprotective mechanism for statins? Heart 2002; 88: 415–416.

Perumal Samy R and Ignacimuthu S. Antibacterial Effects of the Bark of Terminalia

arjuna: Justification of Folklore Beliefs. Pharm biol 2001; 39: 417-420.

Petrie MC, Caruana L, Berry C, McMurray JJV. Diastolic heart failure caused by

subtle left ventricular systolic dysfunction? Heart 2002; 87: 29–31.

Pettit GR, Hoard MS, Doubek DL, Schmidt JM, Pettit RK, Tackett LP, Chapuis JC.

Antineoplastic agents 338. The cancer cell growth inhibitory constituents of

Terminalia arjuna (Combretaceae). J Ethnopharmacol 1996; 53: 57–63.

Pi J, Zhang Q, Fu J, Woods CG, Hou Y, Corkey BE, Collins S, Andersen ME. ROS

signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl

Pharmacol 2010; 244: 77-83.

Piccini JP, Klein L, Gheorghiade M, Bonow RO. New insights into diastolic heart

failure: role of diabetes mellitus. Am J Med 2004, 116(Suppl 5A): 64S-75S.

References


Pickering TG, Gribbin B, Sleight P. Comparison of the reflex heart rate response to

rising and falling arterial pressure in man. Cardiovasc Res 1972; 6: 277–283.

Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumour necrosis

factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000; 67: 291-300.

Pierce GN, Russell JC. Regulation of intracellular Ca2+ in the heart during diabetes.

Cardiovasc Res 1997; 34: 41–7.

Pierson CR, Zhang W, Murakawa Y, Sima AA. Early gene responses of trophic

factors in nerve regeneration differ in experimental type 1 and type 2 diabetic

polyneuropathies. J Neuropathol Exp Neuro 2002; 61: 857–871.

Pradat PF, Kennel P, Maimi-Sadaoui S. Continuous delivery of neurotrophin 3 by

gene therapy has a neuroprotective effect in experimental models of diabetic and

acrylamide neuropathies. Hum Gene Ther 2001; 12: 2237–2249.

Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic

view. Diab Metab Rev 1987; 3: 463-524.

Radhakrishnan R, Wadsworth RM, Gray AI. Terminalia arjuna, an Ayurvedic

cardiotonic, increases contractile force of rat isolated atria. Phytother Res 1993; 7:

266–268.

Ragavan B, Krishnakumari S. Antidiabetic effect of T. arjuna bark extract in alloxan

induced diabetic rats. Indian J Clin Biochem 2006; 21: 123-128.

Ram A, Lauria P, Gupta R, Kumar R, Sharma VS. Hypocholesterolemic effects of

Terminalia arjuna tree bark. J Ethnopharmacol 1997; 55: 165–169.

Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, Sattar N. Statins and all-cause

mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials

involving 65,229 participants. Arch Intern Med 2010; 170 (12): 1024–1031.

Reaven P, Merat S, Casanada F, Sutphin M, Palinski W. Effect of Streptozotocin-

induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts

in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arterioscler

Thromb Vasc Biol 1997; 17: 2250-2256.

References


Ren J and Bode AM. Altered cardiac excitation-contraction coupling in ventricular

myocytes from spontaneously diabetic BB rats. Am J Physiol Heart Circ Physiol 2000,

279: H238-H244.

Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM Jr, Kastelein JJ, Koenig

W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson

JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men

and women with elevated C-reactive protein. N Eng J Med 2008; 359 (21): 2195–

2207.

Rosen P, Du X, Sui GZ. Molecular mechanisms of endothelial dysfunction in the

diabetic heart. Adv Exp Med Biol 2001; 498: 75–86.

Rosenson RS. Pluripotential mechanisms of cardioprotection with HMGCoA

reductase inhibitor therapy. Am J Cardiovasc Drugs 2001; 1: 411–20.

Rossini AA, Liket AA, Chick WI, Appelt MC, Cahill GF. Studies of streptozotocin-

induced insulitis and diabetes. Proc Nati Acad Sci USA 1977; 74: 2485-2489.

Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry,

pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46: 325–415.

Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW,Grishman A. New type

of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;

30: 595–602.

Ruetten H, Thiemermann C. Endothelin-1 stimulates the biosynthesis of tumour

necrosis factor inmacrophages: ET-receptors, signal transduction and inhibition by

dexamethasone. J Physiol Pharmacol 1997; 48: 675–688.

Ryden L, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-

Wilson PA. Efficacy and safety of high-dose lisinopril in chronic heart failure patients

at high cardiovascular risk, including those with diabetes mellitus. Results from the

ATLAS trial. Eur Heart J 2000; 21: 1967–1978.

References


Sasaki S and Bunag RD. Insulin reverses hypertension and hypothalamic depression in

streptozotocin diabetic rats. Hypertension 1983, 5: 34-40.

Schaffer SW and Mozafferi M. Abnormal mechanical function in diabetes: relation to

myocardial calcium handling. Coron Artery Dis 1996; 7: 109–115.

Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal

root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003; 52:

165–171.

Schmidt RE, Dorsey DA, Beaudet LN, Plurad SB, Parvin CA, Miller MS. Insulin-like

growth factor I reverses experimental diabetic autonomic neuropathy. Am J Pathol

1999; 155: 1651–1660.

Severson DL. Diabetic cardiomyopathy: recent evidence from mouse models of type 1

and type 2 diabetes. Can J Physiol Pharmacol 2004; 82: 813– 823.

Shaila HP, Udupa SL, Udupa AL. Hypolipidemic activity of three indigenous drugs in

experimentally induced atherosclerosis. Int J Cardiol 1998; 67: 119–124.

Shailasree S, Ruma K, Kini KR, Niranjana SR, Prakash HS. Potential anti-

inflammatory bioactives from medicinal plants of Western Ghats, India.

Pharmacognosy Communications 2012; 2: 2-12.

Sharma AC, Fogelson BG, Nawas SI, Vigneswaran WT, Sam AD, Alden KJ,

Ferguson J L, Law WR. Elevated coronary endothelin-1 but not nitric oxide in

diabetics during CABG. Ann Thorac Surg 1999; 67: 1659–1663.

Sharma PN, Shoeb PN, Kapil RS, Popli SP. Arjunolone—a new flavone from stem

bark of Terminalia arjuna. Indian J Chem 1982; 21B: 263–264.

Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, Pinkett T, Ghali

JK, Wilson AC: Diabetes mellitus, a predictor of morbidity and mortality in the

Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol

1996; 77: 1017-1020.

References


Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K.

Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the

Zucker fatty rat heart. Diabetes 2002; 51: 1110 –1117.

Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statin-related adverse events: a

meta-analysis. Clin Ther 2006; 28 (1): 26–35.

Singh N, Kapur KK, Singh SP, Shankar K, Sinha JN, Kohli RD. Mechanism of

cardiovascular action of Terminalia arjuna. Planta Med 1982; 45: 102-104.

Singh R, Barden A, Mori T, Beilin, L. Advanced glycation end products: a review.

Diabetologia 2001; 44: 129–146.

Sivalokanathan S, Ilyaaraja M, Balasubramanian MP. Antioxidant activity of

Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular

carcinoma in rats. Mol Cell Biochem 2006; 281: 87–93.

Skundric DS and Lisak RP. Role of neuropoietic cytokines in development and

progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration.

Experimental Diab Res 2003; 4: 303–312.

Smulders RA, Stehouwer CD, Olthof CG, Van Kamp GJ, Teerlink T, de Vries PM,

Donker AJ. Plasma endothelin levels and vascular effects of intravenous L-arginine

infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci

(Lond) 1994; 87: 37- 43.

Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during

sleep in man. A quantitative method for assessing baroreflex sensitivity. Circ Res

1969; 24: 109–121.

Soriano FG, Pacher P, Mabley J, Liaudet L, Szabo C. Rapid reversal of the diabetic

endothelial dysfunction by pharmacological inhibition of poly (ADP-ribose)

polymerase. Circ Res 2001; 89: 684–691.

Soudis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G. Retardation by

aminoguanidine of development of albuminura, mesangial expansion, and tissue

fluorescence in streptozotocininduced diabetic rat. Diabetes 1991; 40: 1328–1334.

References


Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathy: evidence for

apoptosis and associated mitochondrial dysfunction. Diabetes 2000; 49: 1932–1938.

Srivastava RD, Dwivedi S, Sreenivasan KK, Chandrashekhar CN. Cardiovascular

effects of Terminalia species of plants. Indian Drugs 1992; 29: 144–149.

Sugimoto K, Murakawa Y, Sima AAF. Diabetic neuropathy—a continuing enigma.

Diabetes Metab Res Rev 2000; 16: 408–433.

Sumitra M, Manikandan P, Kumar DA, Arutselvan N, Balakrishna K, Manohar BM,

Puvanakrishnan R. Experimental myocardial necrosis in rats: role of arjunolic acid on

platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem 2001; 224:

135–142.

Szkudelski T. The mechanism of Alloxan and Streptozotocin action in B Cells of the

rat pancreas. Physiol Res 2001; 50: 536-546.

Takahashi K, Ghatei MA, Lam HC, O'Hallaran DJ, Bloom SR. Elevated plasma

endothelin in patients with diabetes mellitus. Diabetologia 1990; 33: 306-310.

Takahashi S, Tanaka H, Hano Y, Ito K, Nomura T, Shigenobu K. Hypotensive effects

in rats of hydrophyllic extract from Terminalia arjuna containing tannin-related

compounds. Phytother Res 1997; 1: 424–427.

Tamada A, Hattori Y, Houzen H, Yamada Y, Sakuma I, Kitabatake A, et al. Effects of

beta-adrenoreceptor stimulation on contractility, [Ca2+] i, and Ca2+ current in diabetic

rat cardiomyocytes. Am J Physiol Heart Circ Physiol 1998; 274: H1849–1857.

Tandon S, Rastogi R, Kapoor NK. Protection by abana, a herbomineral preparation,

against myocardial necrosis in rats induced by isoproterenol. Phytother Res 1995; 9:

263–266.

Tankova T, Koev D, Dakovska L. Alpha-lipoic acid in the treatment of autonomic

diabetic neuropathy (controlled, randomized, open-label study). Rom J Intern Med

2004; 42: 457–464.

References


Tauseef M, Sharma KK, Fahim M. Aspirin restores normal baroreflex function in

hypercholesterolemic rats by its antioxidative action. Eur J Pharmacol 2007; 556:

136–143.

Tiwari AK, Gode JD, Dubey GP. Effect of Terminalia arjuna on lipid profiles of

rabbit fed hypercholesterolemic diet. Int J Crude Drug Res 1990; 28: 43–47.

Tomita M, Mukae S, Geshi E, Umetsu K, Nakatani M, Katagiri T. Mitochondrial

respiratory impairment in streptozotocininduced diabetic rat heart. Jpn Circ J 1996;

60: 673–682.

Tomlinson DR. Future prevention and treatment of diabetic neuropathy. Diabetes

Metab. 1998; 24: 79–83.

Tomlinson DR, Fernyhough P, Diemel LT. Role of neurotrophins in diabetic

neuropathy and treatment with nerve growth factors. Diabetes 1997; 46: S43–S49.

Tooke JE. Microvascular function in human diabetes. Diabetes 1995; 44: 721–726.

Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL:

Proinflammatory cytokine levels in patients with depressed left ventricular ejection

fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am

Coll Cardiol 1996; 27: 1201-1206.

Tzivoni D, Gavish A, Zin D, Gottlieb S, Moriel M, Keren A, Banai S, Stern S.

Prognostic significance of ischemic episodes in patients with previous myocardial

infarction. Am J Cardiol 1998; 62: 661– 664.

Ustinova EE, Barrett CJ, Sun SY, Schultz HD. Oxidative stress impairs cardiac

chemoreflexes in diabetic rats. Am J Physiol 2000; 279: 2176 - 2187.

Uusitupa M, Mustonen J, Laakso M, Vainio P, Länsimies E, Talwar S, Pyörälä K.

Impairment of diastolic function in middle aged type 1 and type 2 diabetic patients

free of cardiovascular disease. Diabetologia 1988; 31: 783–791.

Vaidya AB. Terminalia arjuna in cardiovascular therapy. J Assoc Physicians India

1994; 42: 281–282.

References


Van Hoeven KH, Factor SM. A comparison of the pathological spectrum of

hypertensive, diabetic and hypertensive-diabetic heart disease. Circulation 1990; 82:

848-855.

Vane JR, Angaard EA, Botting RM. Regulatory functions of the vascular endothelium.

N Eng J Med 1990; 323: 27-36.

Vinereanu D, Nicolaides E, Boden L, Payne N, Jones CJH, Fraser AG. Conduit

arterial stiffness is associated with impaired left ventricular subendocardial function.

Heart 2003; 89: 449–451.

Vinik AI and Ziegler D. Diabetic Cardiovascular Autonomic Neuropathy. Circulation

2007; 115: 387-397.

Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic Autonomic Neuropathy.

Diabetes Care 2003; 26: 1553–1579.

Wallace A, Chinn D, Rubin G. Taking simvastatin in the morning compared with in

the evening: randomised controlled trial. BMJ 2003; 327 (7418): 788.

Wang P, Lloyd SG, Zeng H, Bonen A, Chatham JC. Impact of altered substrate

utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am J

Physiol Heart Circ Physiol 2005; 288: H2102–H2110.

Warrier PK, Nambiar VPK, Ramankutty C. Terminalia arjuna. In: Warrier, P.K.,

Nambiar, V.P.K., Ramankutty, C. (Eds.), Indian Medicinal Plants—A Compendium of

500 Species, vol. 5, 1st ed. Orient Longman Limited, Madras, India,1996: 253–257.

Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Bohm M et al.

Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression

of the angiotensin II type 1 receptor. Circ Res 2004; 94: 534–541.

Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular

complications. Diabet Med 2001; 18: 945–959.

Wold LE, Ceylan-Isik AF, Ren J. Oxidative stress and stress signaling: menace of

diabetic cardiomyopathy. Acta Pharmacol Sin 2005; 26 (8): 908–917.

References


Wright JR, Colby HD, Miles PR. Cytosolic factors which affect microsomal lipid

peroxidation in lung and liver. Arch Biochem Biophys 1981; 206: 296-304.

Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y,

Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular

endothelial cells. Nature 1998; 332: 411-415.

Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, et al. Catalase protects

cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 2004; 53:

1336–1343.

Ye G, Metreveli NS, Ren J, Epstein PN. Metallothionein prevents diabetes-induced

deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes

2003; 52: 777–783.

Young ME, Mcnulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in

Diabetes: part II Potential mechanisms. Circulation 2002; 105: 1861–1870.

Zhou Y, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger

RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl

Acad Sci U.S.A 2000; 97: 1794–1789.

Ziegler D, Sohr CGH, Nourooz-zadeh J. Oxidative stress and antioxidant defence in

relation to the severity of diabetic polyneuropathy and cardiovascular autonomic

neuropathy. Diabetes Care 2004; 27: 2178–2183.

Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure: abnormalities in active

relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350: 1953–

1959.

Documents

ReferencesReferences - Information and Library …shodhganga.inflibnet.ac.in/bitstream/10603/31654/15/15...References University of Delhi 121 Cai L, Chen S, Evans T, Deng DX, Mukherjee